fce 23884 has been researched along with apomorphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buonamici, M; Cervini, MA; Maj, R; Mantegani, S; Rossi, AC | 1 |
| Buonamici, M; Caccia, C; Carfagna, N; Carminati, P; Cervini, MA; Fariello, RG; Maj, R; Mantegani, S; Rossi, AC | 1 |
2 other study(ies) available for fce 23884 and apomorphine
| Article | Year |
|---|---|
A new dopamine agonist in dopamine deprived systems: FCE 23884.
Topics: Animals; Apomorphine; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Levodopa; Male; Mice; Motor Activity; Reserpine; Time Factors | 1992 |
FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies.
Topics: Animals; Apomorphine; Behavior, Animal; Callithrix; Dogs; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Ergolines; Female; Macaca fascicularis; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Species Specificity | 1991 |